secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zenas BioPharma, Inc. (ZBIO)
CIK:        0001953926
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001104659-24-100177
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zenas BioPharma completes IPO; adopts restated charter and amended bylaws
-------------------------------------------------------------------------

- Authorized 175M shares of common stock and 25M shares of undesignated preferred stock.
- Eliminated stockholder ability to act by written consent and removed prior preferred series references.
- Amended bylaws establish procedures for stockholder proposals and director nominations.
- Charter and bylaws became effective upon IPO consummation on September 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1953926/000110465924100177/0001104659-24-100177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1953926/000110465924100177/tm2332800d24_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-100177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer